Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 1,201–1,225 of 27,380 studies, newest first · page 49 of 1096.

May 2026 25

  1. 2026-05-20

    How bereaved adult-children of parents with dementia use end-of-life caregiving experiences to inform their personal advance care planning

    ✓ Peer-reviewed End-of-life care The Journals of Gerontology Series B

    Key finding: Participants actively contemplated ACP following their parents' death, referring to their end-of-life caregiving experiences as guideposts for issues to anticipate and opportunities to enhance receipt of healthcare during serious illness or incapacitation. +4 more findings

  2. 2026-05-20

    Integrated amyloid, neurodegeneration, and vascular biomarkers estimate the risk of dementia progression in mild cognitive impairment

    ✓ Peer-reviewed Mild cognitive impairment Journal of Alzheimer s Disease

    Key finding: The prominent prognostic role of carotid plaques in Aβ-negative MCI underscores the vascular contributions to non-amyloid cognitive decline and highlights the importance of evaluating both AD-related and vascular mechanisms in prodromal dementia.

  3. 2026-05-20

    A plasma protein signature for cerebral amyloid angiopathy

    ✓ Peer-reviewed Treatments Acta Neuropathologica

    Key finding: Notably, in the new era of disease-modifying treatments for AD, CAA is a significant risk factor for amyloid-related imaging abnormalities (ARIA), an adverse event associated with anti-amyloid treatments. +1 more finding

  4. 2026-05-20

    Young adult urbanicity, late midlife neighborhood disadvantage, and cognitive functioning in community-dwelling older men

    ✓ Peer-reviewed Risk factors The Journals of Gerontology Series B

    Key finding: Compared to those in rural areas, participants who resided in urban areas during young adulthood had lower late midlife ADI (β = -0.85, p < .05), and better executive function (β = 0.19), processing speed (β = 0.24), and verbal fluency (β = 0.30) (ps < .05) in older adulthood. +3 more findings

  5. 2026-05-20

    Smoking Cessation, Weight Change, and Risk of Dementia: A Prospective Cohort Study

    ✓ Peer-reviewed Prevention and risk Neurology

    Key finding: Smoking cessation was associated with a sustained lower dementia risk and slower cognitive decline, comparable to never smokers and those without short-term risk increase. +4 more findings

  6. 2026-05-19

    Beyond Cardiology's Pillars: A Network Meta-Analysis Comparing the Recombinant Zoster Vaccine (Shingrix/RZV) with SGLT2 Inhibitors and GLP-1 Receptor Agonists for Prevention of Major Adverse Cardiovascular Events and Dementia in Adults Aged ≥50 Years

    ⚠ Preprint — not yet peer-reviewed Drug development Research Square

    Key finding: Eligible studies reported MACE or dementia outcomes in adults ≥ 50 years for at least one of three intervention classes (RZV, SGLT2i, GLP-1 RA) versus placebo or active comparator, with follow-up ≥ 6 months. +4 more findings

    Scored 52 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  7. 2026-05-19

    Re: Clarifying comparative claims in digital cognitive assessment: Assessing concurrent validity in a shared cohort

    ✓ Peer-reviewed Cognitive tests and assessment Alzheimer's research & therapy

    Key finding: The assertion that our findings rely on "nonequivalent cohorts" or "outdated regulatory data" is factually incorrect; performance metrics were calculated de novo using the harmonized study dataset. +2 more findings

  8. 2026-05-19

    Prediabetes as a critical stage for risk of dementia and stroke: evidence from the UK Biobank and Mendelian randomization

    ✓ Peer-reviewed Long-term cohort studies European Journal of Preventive Cardiology

    Key finding: During a median 13.7 years of follow-up, prediabetes (n=52,693) was associated with higher risks of vascular dementia (hazard ratio (HR):1.36; 95% confidence interval (CI): 1.14-1.61), stroke (HR:1.09; 95% CI: 1.01-1.16), ischemic stroke (HR:1.10; 95% CI: 1.02-1.19), and intracerebral hemorrhage (HR:1.19; 95% CI: 1.01-1.39) compared with normoglycemia, after adjustment for major confounding factors and across extensive sensitivity analyses. +4 more findings

  9. 2026-05-19

    Sex differences in modifiable risk factors of dementia and their associations with cognition

    ✓ Peer-reviewed Risk factors Biology of Sex Differences

    Key finding: This study included 17,182 participants with a mean age of 69.2 ± 10.6 years, 59.2% of which were women. +4 more findings

  10. 2026-05-19

    Global, regional and country-specific burden of dementia associated with depression across the life-course

    ✓ Peer-reviewed Risk factors Archives of Gerontology and Geriatrics

    Key finding: MDD prevalence was consistently higher among women than men across all regions and age groups, ranging from 4.42%-5.11% in women versus 2.87%-3.41% in men. +4 more findings

  11. 2026-05-18

    Brain endothelial Gαq/11 signalling in cerebrovascular function and cognition of aged mice

    ✓ Peer-reviewed Vascular contributions EBioMedicine

    Key finding: The brain endothelial Gαq/11 signalling pathway preserves normal vascular reactivity, and its loss resembles mild endothelial dysfunction in the brain. +4 more findings

  12. 2026-05-18

    Association of neighborhood deprivation with Alzheimer's Disease pathology, brain structure, and cognition by race and ethnicity, sex, and APOE ε4 status

    ⚠ Preprint — not yet peer-reviewed Risk factors medRxiv : the preprint server for health sciences

    Key finding: We conducted exploratory, linear models testing ADI interactions with sex, race and ethnicity, and APOE ε4, adjusting for age and education. +4 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  13. 2026-05-18

    The AHEPA EEG benchmark: setting the standard for machine learning in dementia diagnosis, a scoping review

    ✓ Peer-reviewed Digital health tools Cognitive Neurodynamics

    Key finding: The open-access AHEPA dataset has become the most commonly used benchmark for Alzheimer's disease (AD) and Frontotemporal dementia (FTD) classification, yet reported results vary widely due to methodological inconsistencies. +3 more findings

  14. 2026-05-18

    Explainable machine learning for predicting longitudinal dementia status: Establishing a leakage-free benchmark

    ✓ Peer-reviewed Digital health tools PLOS Digital Health

    Key finding: XAI analyses revealed that (i) Mini-Mental State Examination and atlas-scaling-factor dynamics dominated SVC decisions, while (ii) education, age, and estimated total intracranial volume were critical for LGBM predictions. +1 more finding

  15. 2026-05-18

    Investigating dementia patterns by machine learning and graph-based marker analysis for multiclass dementia diagnosis

    ✓ Peer-reviewed Getting a diagnosis Discover Computing

    Key finding: Dementia is a debilitating disease that leads to a gradual loss of memory and other cognitive abilities and tends to develop in people over 60 years of age. +1 more finding

  16. 2026-05-18

    Methodological Considerations for Quantile Aggregation in Alzheimer Disease Trials

    ✓ Peer-reviewed Treatments JAMA Neurology

    Key finding: This study evaluates the quantile-aggregation method using both simulated data and publicly available Alzheimer disease randomized trial data.

  17. 2026-05-18

    Spatial heterogeneity and influencing factors of cognitive impairment among elderly hypertensive patients: evidence from rural communities in China

    ✓ Peer-reviewed Risk factors BMC Geriatrics

    Key finding: Central-northern rural communities exhibited the most pronounced high-high spatial clustering of cognitive impairment (Global Moran's I = 0.17, p < 0.001). +4 more findings

  18. 2026-05-18

    Blood biomarkers for Alzheimer disease across ethnoracial groups and healthcare settings: a systematic review and meta-analysis

    ⚠ Preprint — not yet peer-reviewed Tau biomarkers medRxiv

    Key finding: We systematically reviewed 168 publications comprising 139 independent cohorts from Asia, Europe, North America, South America, Africa and Oceania. +3 more findings

    Scored 37 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  19. 2026-05-17

    Prenatal Pesticide Exposure and Early Alzheimer Disease-Related Biomarker and Cognitive Changes in Midlife

    ⚠ Preprint — not yet peer-reviewed Risk factors medRxiv

    Key finding: In this prospective birth cohort study, prenatal exposure to a persistent environmental toxicant was associated with lower plasma Aβ42/40 ratio and worse cognitive performance in midlife, consistent with DDE accelerating the preclinical trajectory of AD-related biological changes decades before symptom onset. +4 more findings

    Scored 44 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  20. 2026-05-17

    Peripheral biomarkers of neuroinflammation in Alzheimer's disease and vascular dementia

    ✓ Peer-reviewed Inflammation and the immune system Biochemical pharmacology

    Key finding: Evidence suggests that neuroinflammation is not merely a downstream response to tissue injury, but actively participates in the bidirectional pathological loop linking Aβ aggregation, tau hyperphosphorylation, and vascular dysfunction.

  21. 2026-05-16

    High-definition Transcranial Direct Current Stimulation Improves Cognitive Function in Patients with Cerebral Small Vessel Disease: An Open-label Pilot Study Informed by Cross-sectional Analysis

    ✓ Peer-reviewed Vascular contributions Current Neuropharmacology

    Key finding: In part 1 of the study, the patients with CSVD showed significant differences in Montreal Cognitive Assessment (MoCA), Auditory Verbal Learning Test (AVLT)-study, AVLT-immediate, AVLT-delay, AVLT-recognition, Trail Making Test (TMT)-A, TMT-B, and Verbal Fluency Test -fruits/vegetables compared with HCs. +4 more findings

  22. 2026-05-16

    Transport pathways across the blood-brain barrier for waste clearance and drug delivery

    ✓ Peer-reviewed Treatments Fluids and Barriers of the CNS

    Key finding: Additionally, this review discusses two other important proteins, which have been less frequently addressed in research regarding transport mechanisms: P-glycoprotein (P-gp) as another transporter at the BBB and proprotein convertase subtilisin/kexin type 9 (PCSK9), a well-known regulator of cholesterol homeostasis which promotes the degradation of the low-density lipoprotein receptor (LDLR) and LRP1. +4 more findings

  23. 2026-05-15

    Real-World Performance of Urine β-amyloid Test Kits in Multiple Hospital Clinics and Neighborhood Communities of China

    ⚠ Preprint — not yet peer-reviewed Treatments medRxiv

    Key finding: Our findings confirm the diagnostic value of urinary β-amyloid protein detection in MCI and AD-related dementia. +4 more findings

    Scored 52 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  24. 2026-05-15

    Associations of gut bacterial classes Clostridia and Deltaproteobacteria with type 2 diabetes and Alzheimer’s disease: A two-sample Mendelian randomization study

    ✓ Peer-reviewed Genetics Medicine

    Key finding: Heterogeneity and directional pleiotropy were assessed, and IVW results were false discovery rate (FDR) corrected using Benjamini-Hochberg. +4 more findings

  25. 2026-05-15

    Proteomic signatures of the APOE ε4 and APOE ε2 genetic variants and Alzheimer's disease

    ✓ Peer-reviewed Genetics Nature Aging

    Key finding: Together, these findings reveal that APOE2 and APOE4 shape Alzheimer's disease risk through distinct molecular architectures and identify candidate biomarkers and targets for allele-specific interventions.

Browse the library by subject, with the full score breakdown →